Cegedim Strategic Data announces the expansion of their EMR-based Real World Patient data and analytics to the US market

JERSEY CITY, N.J., Feb. 5, 2014 (GLOBE NEWSWIRE) -- Cegedim Strategic Data (CSD), a global provider of healthcare research data and services, is pleased to announce the expansion of Longitudinal Patient Data (LPD) to the U.S. market. With more than 20 years of experience in EMR-based (Electronic Medical Records) analytics in Europe and Australia, this addition solidifies CSD's position as a leading provider of real world evidence for Business Intelligence, Epidemiology, and Health Economics/Outcomes research.

CSD's U.S. patient database is sourced from the country's leading provider of ambulatory EMR software. With more than 28 million patients, the database is an unmatched resource for medical and commercial researchers. The detailed anonymised clinical data from routine physician office visits includes patient diagnoses, prescriptions, vital signs, lab test results and more. CSD uses this rich database to provide exceptional solutions that help its partners to uncover insights into the patient journey that only a high-precision data source can provide.

"The Cegedim organization is very excited about this expansion since our clients have been asking for a reliable source of U.S. LPD for many years", commented Bruno Lempernesse, CSD's Chief Operating Officer and US Country Manager. "The new database offers a complete and consistent US and EU5[1] dataset for global research projects."

Fully compliant with US and European privacy requirements, CSD provides a range of research data and analytics from its nationally representative longitudinal patient data sources. Data are extensively used for drug utilization (e.g. treatment patterns, compliance), outcomes research and pharmacoeconomic studies, populating models, health economic evaluations, and natural history of disease. The depth of the US data source allows CSD to provide incidence and prevalence for diagnoses and diseases that would be difficult to achieve with lower-granularity databases.

About Cegedim Strategic Data: Cegedim Strategic Data (CSD) is a leading market research company dedicated to the healthcare industry and operating worldwide. With over 40 years' experience in the pharmaceutical industry, Cegedim Strategic Data offers a comprehensive range of market research services and solutions to its customers, which include more than 50 global and 500 local pharmaceutical companies. CSD integrates primary and secondary analyses with its medical expertise to meet its customer's research needs. To learn more, please visit our website: www.cegedimstrategicdata.com and follow Cegedim Strategic Data on Twitter @CSDCegedim.
About Cegedim: Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,000 people in more than 80 countries and generated revenue of €902 million in 2013. Cegedim SA is listed in Paris (EURONEXT: CGM).

To learn more, please visit: www.cegedim.com and follow Cegedim on Twitter: @CegedimGroup
Contacts: Bruno LEMPERNESSE Cegedim Strategic Data

Chief Operating Officer
USA Country Manager
Tel.: +1 (201) 423 7101
Pauline FAHEY Cegedim Strategic Data
Marketing and Communications
Tel.: +33 (0)1 49 09 83 87

Media Relations
Tel.: +33 (0)1 49 09 68 81

[1] EU5 = France, Germany, UK, Italy, Spain

CSD expands EMR based patient data US market http://hugin.info/141732/R/1758739/594671.pdf